|
|
|
|
“Holding the line against genetically modified crops [...] is mad".
Africa has not always been blessed when it comes to agriculture. Droughts and weather conditions have been the bane of African agriculture for a long time, but they don’t have to be anymore. Innovation has led GMOs to become the miraculous solution in response to pests. They can protect Africa’s harvest and help the continent grow as a whole. GMOs could do wonders for Africa. Read more
Two steps forward for the safety of EU medicines
“European citizens deserve medicines that are safe, of high quality and effective”, stressed Andrzej Rys, Director at DG Sante. To this end and to implement the Falsified Medicines Directive, the European Commission published a new legislative measure that introduces medicine authentication by means of two safety features – a unique identifier and an anti-tampering device. They also took it a step further by digitalising the whole supply chain. Read more
A greener world with PEF
A joint venture has taken place with the goal of producing and marketing FDCA, a material produced from renewable resources which are used to produce PEF, a bio-based plastic that ensures longer shelf life, lowers the amount of packaging material and can be recycled. “The joint venture will further strengthen the global technology and establish the market leadership for FDCA and PEF. With BASF, we plan to start production of FDCA to enable the first commercial launch of this exciting bio-based material and to further develop and grow the market to its full potential”, says CEO of Avantium. Read more
|
|
|
Agricultural biotech
The EU Feed Manufacturers’ Federation (FEFAC) has called on policymakers to stop undermining EU feed and livestock competitiveness with legislative obstacles and administrative burdens. “The GMO ‘opt-out’ proposal for food and feed imports [...] jeopardizes livestock farmers’ access to competitive feed supplies”, Ruud Tijssens, president of FEFAC, said. Read more |
|
|
Healthcare biotech
Should they stay or should they go? BIA - the British BioIndustry Association - says: stay. Brexit would have severe consequences on life sciences and the health care industry. Biotech has developed thanks to EU funding and the UK attracts many leading experts in the matter. All of that could be undone if the UK says go. Read more |
|
|
Industrial biotech
Coca-Cola is seeing green or more specifically: biomass. Coca-Cola, who has already launched its PlantBottle derived from bioethanol-based biomass, would like to expand its circular economy initiative. However, in Europe certain barriers are preventing the firm from going all out biomass: tariffs and duties. Read more
|
|
|
|
|
|
|
|
Biogen is a global biotechnology company based in Cambridge, Massachusetts, established in 1978, in Geneva. One of the pioneers in biotechnology, Biogen today has the leading portfolio of medicines to treat multiple sclerosis (MS) and is at the forefront of research into new medicines for neurodegenerative conditions and rare genetic disorders. Led by world-class research and development, Biogen uses novel science and leading-edge technologies to create, commercialise, and manufacture transformative therapies for patients with few or no treatment options. Our global organisation of more than 7,000 employees is committed to a single mission: making a meaningful difference in the lives of patients suffering from devastating medical conditions. 
